122703696	122703696	CD	B-NP	O
|	|	NNP	I-NP	O
DAMC	DAMC	NNP	I-NP	O
|	|	VBD	B-VP	O
15950200	15950200	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
405696	405696	CD	B-NP	O
|	|	CC	I-NP	O
3/14/2000	3/14/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
R/O	R/O	NNP	I-NP	I-protein
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	I-protein
INFARCTION	INFARCTION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/16/2000	7/16/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/27/2000	2/27/2000	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
STREPTOCOCCAL	STREPTOCOCCAL	NNP	B-NP	O
TRICUSPID	TRICUSPID	NNP	I-NP	O
VALVE	VALVE	NNP	I-NP	O
ENDOCARDITIS	ENDOCARDITIS	NNP	I-NP	O
SECONDARY	SECONDARY	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

LEFT	LEFT	NN	B-NP	B-protein
OPHTHALMITIS	OPHTHALMITIS	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

SEPTIC	SEPTIC	NN	B-NP	O
POLYARTHRITIS	POLYARTHRITIS	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

PACEMAKER	PACEMAKER	NN	B-NP	B-protein
MALFUNCTION	MALFUNCTION	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

DIABETES	DIABETES	NNS	B-NP	O
MELLITUS	MELLITUS	VBZ	B-VP	O
TYPE	TYPE	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	B-protein
ARTERY	ARTERY	NN	I-NP	I-protein
DISEASE	DISEASE	NN	I-NP	I-protein
STATUS	STATUS	NN	I-NP	I-protein
POST	POST	NN	I-NP	I-protein
CORONARY	CORONARY	NN	I-NP	I-protein
ARTERY	ARTERY	NN	I-NP	I-protein
BYPASS	BYPASS	NN	I-NP	I-protein
GRAFTING	GRAFTING	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

PACEMAKER	PACEMAKER	NN	B-NP	B-DNA
PLACEMENT	PLACEMENT	NN	I-NP	I-DNA
7	7	CD	I-NP	I-DNA
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	B-protein
HYPERTENSION	HYPERTENSION	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

OBESITY	OBESITY	NN	B-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

OBSTRUCTIVE	OBSTRUCTIVE	NN	B-NP	O
SLEEP	SLEEP	NN	I-NP	O
APNEA	APNEA	NN	I-NP	O
PROCEDURES	PROCEDURES	NN	I-NP	O
:	:	:	O	O
SEE	SEE	NN	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
54	54	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	grafting	NN	B-NP	O
and	and	CC	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
and	and	CC	I-NP	O
1999	1999	CD	I-NP	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
on	on	IN	B-PP	O
7/16/2000	7/16/2000	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
four	four	CD	I-NP	O
day	day	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
myalgias	myalgia	NNS	B-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
eye	eye	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
decreasing	decrease	VBG	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
experiencing	experience	VBG	I-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
without	without	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
and	and	CC	I-NP	O
fevers	fever	NNS	I-NP	O
to	to	TO	B-PP	O
103	103	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
the	the	DT	B-NP	O
sudden	sudden	JJ	I-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
vision	vision	NN	B-NP	O
loss	loss	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
eye	eye	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
redness	redness	NN	B-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Diamox	Diamox	NN	B-NP	O
,	,	,	I-NP	O
aspirin	aspirin	NN	I-NP	O
and	and	CC	I-NP	O
nitropaste	nitropaste	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
T-wave	T-wave	NN	B-NP	O
inversions	inversion	NNS	I-NP	O
anteriorly	anteriorly	RB	B-ADVP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
and	and	CC	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
broad	broad	JJ	B-NP	O
spectrum	spectrum	NN	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
including	include	VBG	B-PP	O
Ceftriaxone	Ceftriaxone	NN	B-NP	O
,	,	,	I-NP	O
azithromycin	azithromycin	NN	I-NP	O
and	and	CC	I-NP	O
Gentamycin	Gentamycin	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAM	EXAM	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
99.2	99.2	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
118/78	118/78	CD	I-NP	O
,	,	,	O	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
percent	percent	NN	I-NP	O
face	face	NN	I-NP	O
mask	mask	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
OS	OS	NN	B-NP	O
with	with	IN	B-PP	O
hazy	hazy	JJ	B-NP	O
,	,	,	I-NP	O
edematous	edematous	JJ	I-NP	O
cornea	cornea	NN	I-NP	O
,	,	,	O	O
moderately	moderately	RB	B-VP	O
dilated	dilate	VBN	I-VP	O
fixed	fix	VBN	B-NP	O
pupil	pupil	NN	I-NP	O
with	with	IN	B-PP	O
erythema	erythema	NN	B-NP	O
and	and	CC	O	O
injected	inject	VBN	B-NP	O
conjunctiva	conjunctiva	NN	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
without	without	IN	B-PP	O
lymphadenopathy	lymphadenopathy	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Bibasilar	Bibasilar	JJ	B-NP	O
scant	scant	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
Distant	Distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

S3	S3	NN	B-NP	B-protein
,	,	,	O	O
loud	loud	JJ	B-NP	O
S2	S2	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Minimal	Minimal	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
plus	plus	CC	O	O
peripheral	peripheral	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
and	and	CC	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Difficult	Difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
.	.	.	O	O

NEUROLOGICAL	NEUROLOGICAL	NN	B-NP	O
:	:	:	O	O
Nonfocal	Nonfocal	JJ	B-ADJP	O
.	.	.	O	O

RECTAL	RECTAL	NN	B-NP	O
:	:	:	O	O
Guaiac	Guaiac	JJ	B-NP	O
negative	negative	JJ	I-NP	O
brown	brown	JJ	I-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Chemistry	Chemistry	NN	B-NP	O
panel	panel	NN	I-NP	O
showed	show	VBD	B-VP	O
BUN	BUN	NN	B-NP	B-DNA
74	74	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
2.8	2.8	CD	I-NP	I-protein
-LRB-	-LRB-	:	O	I-protein
baseline	baseline	NN	B-NP	I-protein
1.0	1.0	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
normal	normal	JJ	I-ADJP	O
.	.	.	O	O

Albumen	Albuman	NNS	B-NP	O
2.4	2.4	CD	B-NP	O
,	,	,	O	O
liver	liver	NN	B-NP	O
function	function	NN	I-NP	O
studies	study	NNS	I-NP	O
otherwise	otherwise	RB	B-ADJP	O
normal	normal	JJ	I-ADJP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
169	169	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	B-protein
1.7	1.7	CD	I-NP	I-protein
,	,	,	O	O
CBC	CBC	NNP	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
5.5	5.5	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
33	33	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
51	51	CD	B-NP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
showed	show	VBD	B-VP	O
paced	pace	VBN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
with	with	IN	B-PP	O
T-wave	T-wave	JJ	B-NP	O
inversions	inversion	NNS	I-NP	O
of	of	IN	B-PP	O
V1-V6	V1-V6	NN	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
with	with	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
redistribution	redistribution	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
focal	focal	JJ	I-NP	O
infiltrates	infiltrate	NNS	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
essentially	essentially	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
broad	broad	JJ	B-NP	O
spectrum	spectrum	NN	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
rapidly	rapidly	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
72	72	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hydrated	hydrate	VBN	I-VP	O
aggressively	aggressively	RB	B-ADVP	O
and	and	CC	O	O
consistently	consistently	RB	B-ADVP	O
pan	pan	NN	B-NP	O
cultured	culture	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
spike	spike	VB	I-VP	O
fevers	fever	NNS	B-NP	O
from	from	IN	B-PP	O
100	100	CD	B-NP	O
to	to	TO	I-NP	O
101	101	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
grew	grow	VBD	B-VP	O
4/4	4/4	CD	B-NP	O
bottles	bottle	NNS	I-NP	O
of	of	IN	B-PP	O
what	what	WP	B-NP	O
turned	turn	VBD	B-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
Group	Group	NN	B-NP	O
B	B	NN	I-NP	O
streptococcus	streptococcus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Penicillin	Penicillin	NN	B-NP	B-protein
and	and	CC	I-NP	O
Gentamycin	Gentamycin	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
transesophageal	transesophageal	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
any	any	DT	B-NP	O
vegetation	vegetation	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
with	with	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
high	high	JJ	I-NP	O
spiking	spiking	NN	I-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
sepsis	sepsis	NN	B-NP	O
and	and	CC	O	O
4/4	4/4	CD	B-NP	O
blood	blood	NN	I-NP	O
culture	culture	NN	I-NP	O
bottles	bottle	NNS	I-NP	O
,	,	,	O	O
repeated	repeat	VBN	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
growing	grow	VBG	B-VP	O
GBS	GBS	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
repeat	repeat	NN	B-NP	O
transesophageal	transesophageal	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
1.5	1.5	CD	I-NP	O
x1	x1	CD	I-NP	O
.0	.0	CD	I-NP	O
centimeter	centimeter	NN	I-NP	O
vegetation	vegetation	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
annulus	annulus	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
valve	valve	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hitting	hit	VBG	I-VP	O
the	the	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
wire	wire	NN	I-NP	O
though	though	IN	B-SBAR	O
not	not	RB	O	O
fixed	fix	VBN	B-VP	O
to	to	TO	B-PP	O
it	it	PRP	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
bubble	bubble	JJ	I-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
patent	patent	NN	B-NP	O
foramen	foraman	NNS	I-NP	O
ovale	ovale	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
eye	eye	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
vision	vision	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
ophthalmologist	ophthalmologist	NN	I-NP	O
saw	see	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
determined	determine	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
eye	eye	NN	I-NP	O
was	be	VBD	B-VP	O
aspirated	aspirate	VBN	I-VP	O
and	and	CC	O	O
noted	note	VBN	B-VP	O
to	to	TO	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
infected	infect	VBN	I-VP	O
by	by	IN	B-PP	O
GBS	GBS	NNP	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
injected	inject	VBN	I-VP	O
intraocular	intraocular	JJ	B-ADJP	O
with	with	IN	B-PP	O
Vancomycin	Vancomycin	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Unfortunately	Unfortunately	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
spike	spike	VB	I-VP	O
fever	fever	NN	B-NP	O
despite	despite	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
GBS	GBS	NNP	I-NP	B-protein
and	and	CC	O	O
his	his	PRP$	B-NP	O
eye	eye	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
worsening	worsen	VBG	I-VP	O
with	with	IN	B-PP	O
continued	continue	VBN	B-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
conjunctival	conjunctival	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
purulent	purulent	JJ	I-NP	O
exudate	exudate	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
require	require	VB	I-VP	O
enucleation	enucleation	NN	B-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
on	on	IN	B-PP	O
5/10/2000	5/10/2000	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
ten	ten	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
dicloxacillin	dicloxacillin	NN	B-NP	O
and	and	CC	O	O
resolved	resolve	VBN	B-VP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
despite	despite	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
eye	eye	NN	B-NP	O
enucleation	enucleation	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
extensive	extensive	JJ	I-NP	O
work	work	NN	I-NP	O
up	up	RP	B-PRT	O
was	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
fevers	fever	NNS	I-NP	O
including	include	VBG	B-PP	O
evaluation	evaluation	NN	B-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
epidural	epidural	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
,	,	,	O	O
psoas	psoas	NN	B-NP	O
abscess	abscess	NN	I-NP	O
and	and	CC	O	O
infected	infected	JJ	B-NP	O
joints	joint	NNS	I-NP	O
.	.	.	O	O

None	None	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
proved	prove	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
joint	joint	JJ	I-NP	O
aspirations	aspiration	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
see	see	VBP	B-VP	O
musculoskeletal	musculoskeletal	JJ	B-NP	O
section	section	NN	I-NP	O
below	below	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
without	without	IN	B-PP	O
clear	clear	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
tagged	tag	VBN	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
scan	scan	NN	I-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
increased	increase	VBN	B-NP	O
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
,	,	,	O	O
manubrium	manubrium	NN	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ankle	ankle	NN	B-NP	O
and	and	CC	O	O
mid	mid	JJ	B-NP	O
shaft	shaft	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
tibia	tibia	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
interpreted	interpret	VBN	I-VP	O
both	both	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
views	view	NNS	I-NP	O
and	and	CC	O	O
delayed	delay	VBN	B-NP	O
views	view	NNS	I-NP	O
as	as	RB	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
but	but	CC	O	O
not	not	RB	B-ADJP	O
diagnostic	diagnostic	JJ	I-ADJP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
left	left	JJ	B-NP	O
eye	eye	NN	I-NP	O
enucleation	enucleation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
fever	fever	NN	I-NP	O
curve	curve	NN	I-NP	O
trended	trend	VBD	B-VP	O
down	down	RP	B-PRT	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
transesophageal	transesophageal	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
abscess	abscess	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
vegetation	vegetation	NN	I-NP	O
was	be	VBD	B-VP	O
no	no	RB	B-ADJP	O
longer	longer	RBR	I-ADJP	O
visible	visible	JJ	I-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
grade	grade	NN	I-NP	O
fevers	fever	NNS	I-NP	O
were	be	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
ongoing	ongoing	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
infectious	infectious	JJ	I-NP	O
process	process	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
last	last	JJ	I-NP	O
positive	positive	JJ	I-NP	O
blood	blood	NN	I-NP	O
culture	culture	NN	I-NP	O
was	be	VBD	B-VP	O
4/3/2000	4/3/2000	CD	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
fever	fever	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
drug	drug	NN	I-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
once	once	RB	I-ADVP	O
the	the	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
work	work	NN	I-NP	O
up	up	RP	B-PRT	O
was	be	VBD	B-VP	O
completed	complete	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
Penicillin	Penicillin	NNP	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Vancomycin	Vancomycin	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
gram	gram	NN	I-NP	O
positive	positive	JJ	I-NP	O
coverage	coverage	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
four	four	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-SBAR	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
eye	eye	NN	I-NP	O
enucleation	enucleation	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Ophthalmology	Ophthalmology	NN	B-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	B-protein
eye	eye	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	O	O
vision	vision	NN	B-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
presentation	presentation	NN	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
recover	recover	VB	I-VP	O
vision	vision	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
eye	eye	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
his	his	PRP$	B-NP	O
eye	eye	NN	I-NP	O
was	be	VBD	B-VP	O
aspirated	aspirate	VBN	I-VP	O
and	and	CC	O	O
injected	inject	VBN	B-VP	O
with	with	IN	B-PP	O
Vancomycin	Vancomycin	NN	B-NP	O
.	.	.	O	O

Ultimately	Ultimately	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
left	leave	VBN	I-VP	O
eye	eye	NN	B-NP	O
enucleation	enucleation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
eye	eye	NN	I-NP	O
healed	heal	VBD	B-VP	O
well	well	RB	B-ADVP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
thereafter	thereafter	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
extraocular	extraocular	JJ	I-NP	O
muscles	muscle	NNS	I-NP	O
were	be	VBD	B-VP	O
left	leave	VBN	I-VP	O
intact	intact	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
thought	thought	NN	I-NP	O
of	of	IN	B-PP	O
placing	place	VBG	B-VP	O
a	a	DT	B-NP	O
prosthesis	prosthesis	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
date	date	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
T-wave	T-wave	JJ	B-NP	O
inversions	inversion	NNS	I-NP	O
anteriorly	anteriorly	RB	B-ADVP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
it	it	PRP	B-NP	O
rapidly	rapidly	RB	B-ADVP	O
became	become	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
was	be	VBD	B-VP	O
malfunctioning	malfunction	VBG	I-VP	O
demonstrating	demonstrate	VBG	I-VP	O
only	only	RB	B-NP	O
occasional	occasional	JJ	I-NP	O
pacing	pacing	NN	I-NP	O
spikes	spike	NNS	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
6/24/2000	6/24/2000	CD	B-NP	O
the	the	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
was	be	VBD	B-VP	O
no	no	RB	I-VP	O
longer	longer	RB	I-VP	O
capturing	capture	VBG	I-VP	O
or	or	CC	I-VP	O
sensing	sense	VBG	I-VP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
wire	wire	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
incorporated	incorporate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
vegetation	vegetation	NN	I-NP	O
noted	note	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
valve	valve	NN	I-NP	O
however	however	RB	B-ADVP	O
it	it	PRP	B-NP	O
did	do	VBD	B-VP	O
appear	appear	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
vegetation	vegetation	NN	I-NP	O
was	be	VBD	B-VP	O
hitting	hit	VBG	I-VP	O
the	the	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
wire	wire	NN	I-NP	O
with	with	IN	B-PP	O
systole	systole	NN	B-NP	O
and	and	CC	I-NP	O
diastole	diastole	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/13/2000	6/13/2000	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
pacemaker	pacemaker	NN	B-NP	O
explantation	explantation	NN	I-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
indication	indication	NN	I-NP	O
for	for	IN	B-PP	O
pacemaker	pacemaker	NN	B-NP	O
placement	placement	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
for	for	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
concern	concern	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
become	become	VB	I-VP	O
bradycardic	bradycardic	JJ	B-ADJP	O
without	without	IN	B-PP	O
his	his	PRP$	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
however	however	RB	B-ADVP	O
this	this	DT	B-NP	O
never	never	RB	I-NP	O
manifested	manifest	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
problem	problem	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
some	some	DT	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
but	but	CC	O	O
this	this	DT	B-NP	O
resolved	resolve	VBD	B-VP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
sepsis	sepsis	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
supraventricular	supraventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
1-1	1-1	JJ	B-NP	O
conduction	conduction	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	B-protein
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
this	this	DT	B-NP	O
dose	dose	NN	I-NP	O
without	without	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
or	or	CC	I-NP	O
hypotension	hypotension	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
transesophageal	transesophageal	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
percent	percent	NN	I-NP	O
,	,	,	O	O
apical	apical	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
moderately	moderately	RB	B-NP	O
dilated	dilate	VBN	I-NP	O
right	right	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
with	with	IN	B-PP	O
moderately	moderately	RB	B-NP	O
depressed	depressed	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
vena	vena	NN	I-NP	O
cava	cava	NN	I-NP	O
dilatation	dilatation	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	O
function	function	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
One	One	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
major	major	JJ	I-NP	O
presenting	present	VBG	I-NP	O
complaints	complaint	NNS	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-NP	O
arthralgia	arthralgia	NN	I-NP	O
and	and	CC	I-NP	O
myalgia	myalgia	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
though	though	IN	B-SBAR	O
that	that	DT	B-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
ophthalmitis	ophthalmitis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
could	could	MD	B-VP	O
have	have	VB	I-VP	O
septic	septic	JJ	B-NP	O
polyarthritis	polyarthritis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
several	several	JJ	B-NP	O
arthrocentesis	arthrocentesis	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
rheumatology	rheumatology	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

Though	Though	IN	B-SBAR	O
the	the	DT	B-NP	O
fluid	fluid	NN	I-NP	O
did	do	VBD	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
elevated	elevated	JJ	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
never	never	RB	B-ADVP	O
clear	clear	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
acutely	acutely	RB	B-ADJP	O
infected	infected	JJ	I-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
on	on	IN	B-PP	O
gram	gram	NN	B-NP	O
stain	stain	NN	I-NP	O
or	or	CC	I-NP	O
culture	culture	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
tender	tender	NN	B-NP	O
,	,	,	O	O
erythematous	erythematous	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
warm	warm	JJ	I-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
arthroscopic	arthroscopic	JJ	B-NP	O
examination	examination	NN	I-NP	O
on	on	IN	B-PP	O
7/16/2000	7/16/2000	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
knee	knee	NN	I-NP	O
was	be	VBD	B-VP	O
lavaged	lavage	VBN	I-VP	O
with	with	IN	B-PP	O
9	9	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
sterile	sterile	JJ	B-NP	O
saline	saline	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
closing	close	VBG	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
effusion	effusion	NN	I-NP	O
was	be	VBD	B-VP	O
drained	drain	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
effusion	effusion	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
10/28/2000	10/28/2000	CD	B-NP	O
for	for	IN	B-PP	O
repeat	repeat	NN	B-NP	O
arthrocentesis	arthrocentesis	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
has	have	VBZ	B-VP	O
reaccumulated	reaccumulate	VBN	I-VP	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
sized	sized	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
regained	regain	VBN	I-VP	O
a	a	DT	B-NP	O
moderate	moderate	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
this	this	DT	B-NP	O
effusion	effusion	NN	I-NP	O
drained	drain	VBD	B-VP	O
again	again	RB	B-ADVP	O
because	because	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
warm	warm	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
erythematous	erythematous	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
left	left	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
quite	quite	RB	I-VP	O
tender	tender	VB	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
joint	joint	JJ	I-NP	O
aspirations	aspiration	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
glenohumeral	glenohumeral	JJ	I-NP	O
and	and	CC	I-NP	O
acromioclavicular	acromioclavicular	JJ	I-NP	O
joints	joint	NNS	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
side	side	NN	I-NP	O
and	and	CC	B-PP	O
under	under	IN	B-PP	O
fluoroscopic	fluoroscopic	JJ	B-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
joint	joint	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
elevated	elevated	JJ	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
but	but	CC	O	O
never	never	RB	B-ADVP	O
any	any	DT	B-NP	O
clear	clear	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
septic	septic	JJ	I-NP	O
joint	joint	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
eye	eye	NN	I-NP	O
enucleation	enucleation	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
CK	CK	NN	I-NP	O
of	of	IN	B-PP	O
1522	1522	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
insignificant	insignificant	JJ	I-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
enough	enough	JJ	B-NP	O
manipulation	manipulation	NN	I-NP	O
to	to	TO	B-PP	O
skeletal	skeletal	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
enucleation	enucleation	NN	I-NP	O
to	to	TO	B-VP	O
warrant	warrant	VB	I-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
CK	CK	NN	B-NP	O
did	do	VBD	B-VP	O
coincide	coincide	NN	B-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
muscle	muscle	NN	I-NP	O
aches	ache	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
perhaps	perhaps	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
rhabdomyolysis	rhabdomyolysis	NN	B-NP	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
quickly	quickly	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
CK	CK	NN	I-NP	B-protein
of	of	IN	B-PP	O
177	177	CD	B-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
experiencing	experience	VBG	I-VP	O
no	no	DT	B-NP	O
myalgias	myalgia	NNS	I-NP	O
or	or	CC	I-NP	O
arthralgias	arthralgia	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
somewhat	somewhat	RB	B-ADJP	O
limited	limited	JJ	I-ADJP	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
and	and	CC	O	O
demonstrates	demonstrate	VBZ	B-VP	O
an	an	DT	B-NP	O
effusion	effusion	NN	I-NP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
responding	respond	VBG	I-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
maintained	maintain	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
on	on	IN	B-PP	O
high	high	JJ	B-NP	O
flow	flow	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
however	however	RB	B-ADVP	O
was	be	VBD	B-VP	O
quickly	quickly	RB	I-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
and	and	CC	B-NP	O
then	then	RB	I-NP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
and	and	CC	O	O
used	use	VBD	B-VP	O
his	his	PRP$	B-NP	O
BIPAP	BIPAP	NN	I-NP	B-protein
at	at	IN	B-PP	O
night	night	NN	B-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
nadir	nadir	NN	I-NP	O
of	of	IN	B-PP	O
51	51	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
has	have	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
his	his	PRP$	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
538	538	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
hematocrit	hematocrit	NN	B-NP	O
that	that	WDT	B-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
and	and	CC	O	O
corresponded	correspond	VBD	B-VP	O
to	to	TO	B-PP	O
some	some	DT	B-NP	O
guaiac	guaiac	JJ	I-NP	O
positive	positive	JJ	I-NP	O
stools	stool	NNS	I-NP	O
with	with	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
reticulocyte	reticulocyte	NN	I-NP	O
count	count	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
ultimately	ultimately	RB	B-ADVP	O
with	with	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
HS	HS	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
2-3	2-3	NN	I-NP	O
range	range	NN	I-NP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.0	1.0	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
dehydration	dehydration	NN	B-NP	O
and	and	CC	O	O
prerenal	prerenal	JJ	B-NP	O
azotemia	azotemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
reached	reach	VBD	B-VP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
3.0	3.0	CD	B-NP	O
and	and	CC	O	O
stabilized	stabilize	VBD	B-VP	O
at	at	IN	B-PP	O
1.3	1.3	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
resolved	resolve	VBN	I-VP	O
entirely	entirely	RB	B-ADVP	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
and	and	CC	I-NP	O
rehydration	rehydration	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Fluids/electrolytes/nutrition	Fluids/electrolytes/nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
dehydrated	dehydrate	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
responded	respond	VBD	B-VP	O
rapidly	rapidly	RB	B-ADVP	O
to	to	TO	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
fertilization	fertilization	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
regained	regain	VBD	B-VP	O
his	his	PRP$	B-NP	O
appetite	appetite	NN	I-NP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
sepsis	sepsis	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
noted	note	VBN	I-VP	O
however	however	RB	B-ADVP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
poor	poor	JJ	I-NP	O
albumen	albuman	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
2.3	2.3	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
improved	improved	JJ	B-NP	O
nutrition	nutrition	NN	I-NP	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
and	and	CC	O	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
standing	standing	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
metformin	metformin	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
10	10	CD	I-NP	O
q	q	NN	I-NP	O
a.m.	a.m.	RB	B-ADVP	O
and	and	CC	O	O
10	10	CD	B-NP	O
q	q	NN	I-NP	O
p.m.	p.m.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
25	25	CD	I-NP	I-protein
q	q	NN	I-NP	I-protein
a.m.	a.m.	RB	B-ADVP	O
and	and	CC	O	O
20	20	CD	B-NP	O
q	q	NN	I-NP	O
p.m.	p.m.	RB	B-ADVP	O
His	His	PRP$	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
A1-C	A1-C	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
8.1	8.1	CD	B-NP	O
in	in	IN	B-PP	O
11/15	11/15	CD	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
metformin	metformin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
anticipation	anticipation	NN	I-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
invasive	invasive	JJ	I-NP	O
procedures	procedure	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
maintained	maintained	JJ	B-NP	O
and	and	CC	I-NP	O
NPH	NPH	NN	I-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
metformin	metformin	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
recovers	recover	VBZ	B-VP	O
further	further	RBR	B-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
develop	develop	VB	I-VP	O
guaiac	guaiac	JJ	B-NP	O
positive	positive	JJ	I-NP	O
stools	stool	NNS	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
once	once	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
made	make	VBN	I-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
recovery	recovery	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
transaminitis	transaminitis	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
resolved	resolve	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
from	from	IN	B-PP	O
Penicillin	Penicillin	NNP	B-NP	O
to	to	TO	B-PP	O
Vancomycin	Vancomycin	NNP	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Ilotycin	Ilotycin	NN	B-NP	O
0.5	0.5	CD	I-NP	O
%	%	NN	I-NP	O
topical	topical	JJ	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
over	over	IN	B-PP	O
left	left	JJ	B-NP	O
eyelid	eyelid	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
8	8	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
a.m.	a.m.	RB	B-ADVP	O
and	and	CC	O	O
3	3	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
50	50	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q	q	NN	I-NP	I-protein
a.m.	a.m.	RB	B-ADVP	O
and	and	CC	O	O
35	35	CD	B-NP	O
units	unit	NNS	I-NP	O
q	q	NN	I-NP	O
p.m.	p.m.	RB	B-ADVP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
15	15	CD	B-NP	O
units	unit	NNS	I-NP	O
q	q	NN	I-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	O	O
q	q	NN	B-NP	O
HS	HS	NN	I-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
q	q	NN	I-NP	O
AC	AC	NN	I-NP	O
and	and	CC	I-NP	O
HS	HS	NN	I-NP	O
.	.	.	O	O

Metoprolol	Metoprolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
Metamucil	Metamucil	NNP	B-NP	O
two	two	CD	B-NP	O
packets	packet	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
with	with	IN	B-PP	O
minerals	mineral	NNS	B-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Vancomycin	Vancomycin	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
intravenously	intravenously	RB	B-NP	O
q	q	NN	I-NP	O
12	12	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
q	q	NN	I-NP	I-protein
day	day	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
110	110	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
trandolapril	trandolapril	NN	B-NP	B-protein
p.o.	p.o.	FW	I-NP	I-protein
b.i.d.	b.i.d.	FW	I-NP	I-protein
-LRB-	-LRB-	FW	I-NP	I-protein
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
110	110	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q	q	NN	I-NP	O
4	4	CD	B-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
headache	headache	NN	I-NP	O
,	,	,	O	O
Droperidol	Droperidol	NN	B-NP	O
0.625	0.625	CD	I-NP	O
mg	mg	NN	I-NP	O
intravenously	intravenously	RB	B-NP	O
q	q	NN	I-NP	O
6	6	CD	B-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
one	one	CD	I-NP	I-protein
tablet	tablet	NN	I-NP	I-protein
sublingual	sublingual	JJ	I-NP	I-protein
q	q	NN	I-NP	I-protein
5	5	CD	B-NP	I-protein
minutes	minute	NNS	I-NP	I-protein
times	times	CC	B-NP	I-protein
3	3	CD	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
Serax	Serax	NN	B-NP	O
15-30	15-30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
HS	HS	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
insomnia	insomnia	NN	I-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
1-2	1-2	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
4h	4h	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
syrup	syrup	NN	I-NP	O
2	2	CD	B-NP	O
teaspoons	teaspoon	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q	q	NN	I-NP	O
HS	HS	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

ACTIVITY	ACTIVITY	NN	B-NP	O
:	:	:	O	O
Per	Per	NN	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
ADA	ADA	NN	B-NP	O
2200	2200	CD	I-NP	O
calorie	calorie	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
saturated	saturate	VBN	I-NP	O
fat	fat	NN	I-NP	O
and	and	CC	I-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
EDGARDO	EDGARDO	NNP	B-NP	O
GOTTKE	GOTTKE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QY93	QY93	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BENTON	BENTON	NNP	B-NP	O
B.	B.	NNP	I-NP	O
MODENA	MODENA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
HF40	HF40	NNP	I-NP	O
YK634/8224	YK634/8224	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
5705	5705	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

H4SV4M57I2	H4SV4M57I2	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
8/10	8/10	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/10	8/10	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
DWAYNE	DWAYNE	NNP	B-NP	O
KENNY	KENNY	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
CORKILL	CORKILL	NNP	I-NP	O

